ACLA Press Releases

  • ACLA President Julie Khani Outlines Key Challenges Facing Testing Capacity

    March 29, 2020
    WASHINGTON, D.C. – Today, ACLA President Julie Khani released the following statement: “One month ago today, the FDA cleared the regulatory barriers preventing commercial labs from performing COVID-19 testing. Since then, ACLA member laboratories have steadily increased COVID-19 testing capacity each week. In total, ACLA members have performed approximately 650,000 COVID-19 tests to date, including 84,000 tests completed just yesterday. We currently have six ACLAContinue Reading »...
  • ACLA Statement on CARES Act

    March 25, 2020
    WASHINGTON, D.C. – Following the release the Coronavirus Aid, Relief, and Economic Security Act this evening, ACLA President Julie Khani released the following statement: “For the third time, Congress has failed to provide the necessary funds to support ‘free testing’ for all Americans. Our members remain in an untenable situation, absorbing growing, uncompensated costs for testing specimens with no assurance that they will be appropriately or fairlyContinue Reading »...
  • With Congress on its third financial relief package, policymakers fail to recognize critical role of labs

    March 23, 2020
    WASHINGTON, D.C. — As policymakers close in on a third financial relief package, ACLA President Julie Khani issued the following statement: “We are on the cusp of the U.S. Congress finalizing a third legislative financial relief package to address the coronavirus response.  It is disappointing and alarming that Congress has not yet recognized the contributions of the lab industry and its response during this publicContinue Reading »...
  • ACLA Statement on Senate COVID-19 Response Effort

    March 22, 2020
    WASHINGTON, D.C — Following the release of the latest Senate legislation in response to the COVID-19 pandemic, ACLA President Julie Khani released the following statement: “We are alarmed by the latest Senate proposal – it fails to clearly designate essential emergency funding for expanded testing capacity and laboratory operations. If this legislation moves forward, it would set up commercial laboratories to perform COVID-19 testing atContinue Reading »...
  • Without sustainable funding, there is simply no way to have sustainable testing

    March 21, 2020
    WASHINGTON, D.C. – Following today’s White House briefing, ACLA President Julie Khani released the following statement: “As the White House pointed out today, commercial labs are rapidly ramping up testing capacity. Since the FDA first provided an accelerated path for commercial labs to respond to the COVID-19 outbreak, ACLA laboratories have collectively reported out approximately 129,000 tests to date, including 41,000 tests performed just yesterday.Continue Reading »...
  • ACLA Statement on Stimulus Bill

    March 20, 2020
    WASHINGTON, D.C. — ACLA President Julie Khani today issued the following statement regarding the current stimulus bill under consideration in the Senate: “ACLA members have collectively reported out approximately 88,000 COVID-19 tests to date, including 25,000 tests performed just yesterday. As we continue to scale up capacity, the current stimulus bill under consideration in the Senate would not provide the sufficient backing for ourContinue Reading »...
  • Facing Unprecedented Demand for Testing, Clinical Labs Ask Congress for Surge Capacity Fund

    March 19, 2020
    WASHINGTON, D.C. — As commercial laboratories rapidly extend considerable resources to meet demand for COVID-19 testing, ACLA President Julie Khani sent a letter to congressional leadership seeking support from the federal government. “We are growing increasingly concerned that the federal government is not recognizing the strain on the laboratory industry to meet the demand for testing for COVID-19,” writes Khani. As policymakers consider measuresContinue Reading »...
  • Statement on Recent FDA Actions To Expand COVID-19 Testing

    March 17, 2020
    WASHINGTON, D.C. – Following the FDA’s actions announced on March 16, ACLA President Julie Khani released the following statement: “The FDA’s guidance released on Saturday, February 29th cleared the regulatory hurdles to allow commercial labs to immediately begin testing patients as soon as test validation was complete, and our members began accepting specimens for testing less than a week later. The FDA has recently taken several positive steps toContinue Reading »...
  • Commercial Labs Step Up Capacity, Collaborate With Public Health Partners To Respond To National Emergency

    March 13, 2020
    Commercial capacity is expected to exceed 20,000 tests per day nationwide by end of next week, 280,000 tests per week by April 1. WASHINGTON, D.C. – Commercial laboratories have stepped up to bring critical COVID-19 testing capacity to the U.S. health care system. Following the FDA’s guidance on February 29 that provided an accelerated path for commercial laboratories to perform COVID-19 testing, commercial laboratoriesContinue Reading »...
  • Commercial Labs Announce Plans to Provide COVID-19 Testing

    March 05, 2020
    WASHINGTON, D.C. – The FDA’s latest guidance released over the weekend provided an accelerated path for high-complexity laboratories to support additional testing capacity in response to the COVID-19 outbreak. Prior to Saturday’s announcement, ACLA members were already working to develop novel tests for COVID-19. Additionally, we have been in close communication with public health agencies since January as part of our existing memorandum of understanding with the CDC, the Association of PublicContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18